CD14 and non-Hodgkin lymphoma: Comparative analysis among NHL types indicated the highest percentage of CD14+HLA-DRlow/− monocytes in patients with diffuse large B-cell lymphoma (DLBCL) comparing to follicular or indolent lymphoma.